4th Quarter - Termination

COVIDIEN LP for COVIDIEN LP

Firm
Client
Income
—
Expenses
$40,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Dec 23, 2017

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to the continued suspension and repeal of the medical device tax H.R.184 - Protect Medical Innovation Act of 2017 S.108 - Medical Device Access and Innovation Protection Act International tax issues including OUS earnings and territorial tax reform proposals H.R. 1/P.L. 115-97, The Tax Cuts and Jobs Act Tax policy proposals relating to Puerto Rico

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (115th), S. 108 (115th), H.R. 184 (115th)

Health Issues HCR

P.L. 115-52, The FDA Re-authorization Act (FDARA)- Issues related to the re-authorization of the Medical Device User Fees, facility inspections, 3rd party servicing of medical devices, and risked based classifications of accessories Issues related to value based healthcare and modernization of fraud and abuse laws Issues related to opioids/chronic pain Issues relating to natural disaster recovery efforts

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Veterans VET

Issues related to VA procurement and devices

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.